http://asbestos.vieiratriallaw.com/ en-us 2006-07-04T18:08:10-08:00 http://asbestos.vieiratriallaw.com/archives/-qa-latest-treatments-for-mesothelioma.html Researchers are studying whether chemotherapy before surgery and radiation can deter tumor recurrence in patients with mesothelioma, a rare cancer of the lining of the chest caused by asbestos exposure. Tony Vieira 2006-07-04T18:08:10-08:00 http://asbestos.vieiratriallaw.com/archives/-mesothelioma-treatment-options-ii.html Treatment Options for Malignant Mesothelioma Localized Malignant Mesothelioma (Stage I) If the malignant mesothelioma is in one part of the chest lining, treatment will probably be surgery to remove the part of the chest lining with cancer and some of... Tony Vieira 2006-06-29T16:15:02-08:00 http://asbestos.vieiratriallaw.com/archives/mesothelioma-treatment-options-new-mesothelioma-treatments.html Implantable Device May Offer Better Pain Management National Cancer Institute Patients with advanced cancer who used an implantable drug-delivery device to control their pain had better pain relief, fewer toxic side effects, and better survival than patients who received intensive... Mesothelioma Treatment Options Tony Vieira 2006-06-29T16:04:02-08:00 http://asbestos.vieiratriallaw.com/archives/-mesothelioma-faqs-how-is-mesothelioma-treated.html Treatment for mesothelioma depends on the location of the cancer, the stage of the disease, and the patient's age and general health. Standard treatment options include surgery, radiation therapy, and chemotherapy. Sometimes, these treatments are combined.... Mesothelioma FAQ's Tony Vieira 2006-06-22T17:06:30-08:00 http://asbestos.vieiratriallaw.com/archives/-casecontrol-study-of-cancer-among-us-army-veterans-exposed-to-simian-virus-40contaminated-adenovirus-vaccine.html Case-Control Study of Cancer among US Army Veterans Exposed to Simian Virus 40-contaminated Adenovirus Vaccine Tony Vieira 2006-06-04T18:37:14-08:00 http://asbestos.vieiratriallaw.com/archives/-largestyet-mesothelioma-study-shows-survival-benefit-with-new-drug.html Largest-Yet Mesothelioma Study Shows Survival Benefit with New Drug Tony Vieira 2006-06-04T18:30:28-08:00 http://asbestos.vieiratriallaw.com/archives/-phase-ii-trials-of-surgical-resection-and-adjuvant-highdose-hemithoracic-radiation-for-malignant-pleural-mesothelioma.html Phase II trials of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. Tony Vieira 2006-06-04T18:24:41-08:00 http://asbestos.vieiratriallaw.com/archives/-phase-iii-study-of-pemetrexed-in-combination-with-cisplatin-versus-cisplatin-alone-in-patients-with-malignant-pleural-mesothelioma.html Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma Tony Vieira 2006-06-04T18:22:15-08:00 http://asbestos.vieiratriallaw.com/archives/-updated-analysis-in-secondline-treatment-of-lung-cancer-trial-confirms-similar-survival-for-alimtar-and-docetaxel.html Updated Analysis in Second-Line Treatment of Lung Cancer Trial Confirms Similar Survival for Alimta(R) and Docetaxel Tony Vieira 2006-06-04T18:17:04-08:00 http://asbestos.vieiratriallaw.com/archives/-medical-and-civil-justice-communities-mourn-the-loss-of-mesothelioma-advocate-terry-mccann.html Terry McCann, Olympic gold medalist, Toastmaster CEO, and asbestos victims rights advocate, died yesterday from malignant mesothelioma. Tony Vieira 2006-06-03T16:08:31-08:00 http://asbestos.vieiratriallaw.com/archives/mesothelioma-treatment-options-are-new-treatments-being-studied.html Yes. Because mesothelioma is very hard to control, the National Cancer Institute (NCI ) is sponsoring clinical trials (research studies with people) that are designed to find new treatments and better ways to use current treatments. Before any new treatment... Mesothelioma Treatment Options Tony Vieira 2006-05-21T02:13:06-08:00 http://asbestos.vieiratriallaw.com/archives/-curagen-and-topotarget-announce-initiation-of-ncisponsored-phase-ii-clinical-trial-with-pxd101-for-mesothelioma.html CuraGen Corporation (Nasdaq: CRGN - News) and TopoTarget A/S (Copenhagen Stock Exchange: TOPO) announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National Cancer Institute (NCI) under a Clinical Trials Agreement with CuraGen for the clinical development of PXD101. Tony Vieira 2006-05-03T16:19:10-08:00 http://asbestos.vieiratriallaw.com/archives/-new-research-findings-published-in-national-academy-of-sciences-journal-show-promise-of-onconase-for-mesotheliom-and-lung-cancer-caused-by-asbestos.html ONCONASE(R) (ranpirnase) may be one of the most effective methods of treatment for mesothelioma and lung cancer caused by this mechanism, and may even reduce the incidence of these cancers in those exposed to asbestos. Tony Vieira 2006-05-03T16:14:26-08:00 http://asbestos.vieiratriallaw.com/archives/-largestyet-mesothelioma-study-shows-survival-benefit-with-new-drug.html Largest-Yet Mesothelioma Study Shows Survival Benefit with New Drug Tony Vieira 2006-04-04T18:40:21-08:00 http://asbestos.vieiratriallaw.com/archives/-asbestos-faqs-australia-severely-restricts-chrysotile.html Uses of chrysotile asbestos in Australia have now been banned as a result of the regulatory action except for certain limited exemptions. ]]> Asbestos FAQ's Tony Vieira 2006-03-16T08:33:49-08:00